Thinking of joining a study?

Register your interest

NCT06342401 | RECRUITING | Colorectal Cancer


Early Onset Colorectal Cancer Detection
Sponsor:

City of Hope Medical Center

Brief Summary:

Colorectal cancer (CRC) once predominantly affected older individuals, but in recent years has witnessed a progressive increase in incidence among young adults. Once rare, early-onset colorectal cancer (EOCRC, that is, a CRC diagnosed before the age of 50) now constitutes 10-15% of all newly diagnosed CRC cases and it stands as the first cause of cancer-related death in young men and the second for young women. This study aims to detect EOCRC with a non-invasive test, using a blood-based molecular assay based on microRNA (ribonucleic acid)

Condition or disease

Colorectal Cancer

Colorectal Neoplasms

Colorectal Adenocarcinoma

Colorectal Cancer Stage I

Colorectal Cancer Stage IV

Colorectal Cancer Stage II

Colorectal Cancer Stage III

Colorectal Neoplasms Malignant

Intervention/treatment

ENCODE

Detailed Description:

The rising incidence of early-onset colorectal cancer (EOCRC) is a pressing clinical issue unique to our times, and it is expected to grow with an anticipated further 90% increase in incidence by the decade's end. Challenges persist even after reducing the CRC screening age to 45: under-45s lack routine screening and compliance in the 45-50 age group remains low, partly due to invasiveness and discomfort of standard screening methods. Urgent action is warranted to develop affordable, sensitive, and feasible screening for timely detection and improved participation. A non-invasive, patient-friendly screening test, like a blood-based assay, could address these epidemiological concerns and also attract underserved populations. This study involves the development and validation of a liquid biopsy, assessing circulating cell-free and exosomal microRNAs (cf-miRNA and exo-miRNA, respectively) for indirect sampling of tumor tissue in the bloodstream. The researchers intend to harness machine learning and bioinformatics to create an integrated panel (with both cf-miRNAs and exo-miRNAs) to enhance the inherently high sensitivity of cf-miRNAs with the distinctive specificity of exo-miRNAs. This combined approach will not only improve the performance of a diagnostic model but will also tap into the diverse tumor biology aspects of EOCRC. The study's core goal is to develop cost-efficient, non-invasive, clinic-friendly biomarkers with high sensitivity and specificity, aiding EOCRC detection. The researchers intend to do so in three phases: 1. To perform comprehensive small RNA-Seq from matched cf-miRNA, exo-miRNA, cancer-derived miRNA, and mucosa-derived miRNA. 2. To develop and train two miRNA detection panels (cf-miRNA and exo-miRNA, respectively) based on advanced machine-learning models and, then, combine these two using several machine-learning models to obtain a final detection biomarker. 3. To validate the findings in an independent cohort of EOCRC and controls. In summary, this proposal promises to improve patient care and compliance, and, ultimately, reduce mortality from EOCRC.

Study Type : OBSERVATIONAL
Estimated Enrollment : 400 participants
Official Title : Development and Validation fo an Exosome-Based and Machine Learning Powered Liquid Biopsy for the Detection of Early-Onset Colorectal Cancer
Actual Study Start Date : 2023-04-15
Estimated Primary Completion Date : 2025-10-15
Estimated Study Completion Date : 2025-10-15

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years to 50 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: 1
Criteria
Inclusion Criteria
  • * Stage I, II, III, IV colorectal cancer (TNM classification, 8th edition) diagnosed before the age of 50 (EOCRC cases)
  • * Received standard diagnostic and staging procedures as per local guidelines, and at least one sample was drawn before receiving any curative-intent treatment
  • * Colonoscopy-proven cancer-free status at the time of study inclusion (Non-disease controls)
Exclusion Criteria
  • * Hereditary colorectal cancer syndromes (identified through genetic testing)
  • * Inflammatory bowel diseases
  • * Lack of written informed consent

Early Onset Colorectal Cancer Detection

Location Details

NCT06342401


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


RECRUITING

United States, California

City of Hope Medical Center

Duarte, California, United States, 91010

RECRUITING

Italy,

IRCCS San Raffaele

Milan, Italy,

RECRUITING

Japan,

Kawasaki University

Kawasaki, Japan,

RECRUITING

Japan,

Mie University

Mie, Japan,

RECRUITING

Japan,

National Cancer Center Hospital

Tokyo, Japan,

RECRUITING

Japan,

Tokyo Medical and Dental University

Tokyo, Japan,

RECRUITING

Japan,

Yamagata University

Yamagata, Japan,

RECRUITING

Spain,

Barcelona University

Barcelona, Spain,

RECRUITING

Spain,

Colorectal Surgery, Hebron Valley University Hospital, Independent University of Barcelona UAB

Barcelona, Spain,

RECRUITING

Spain,

Surgery Department, Hospital del Mar, Barcelona, Spain

Barcelona, Spain,

RECRUITING

Spain,

University of La Laguna

The lagoon, Spain,

RECRUITING

Spain,

Salamanca Biomedical Research Institute

Madrid, Spain,

RECRUITING

Spain,

University of Salamanca-Sacyl-CSIC, Salamanca, Spain

Salamanca, Spain,

Loading...